Genzyme was an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme (also known as Genzyme Transgenics...

and later acquired by Genzyme. It is marketed in the U.S. by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada...

eosinophils. It was developed by Regeneron Pharmaceuticals and Sanofi Genzyme. It received approval from the US Food and Drug Administration (FDA) for...

corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech...

make its name easier to pronounce in countries such as China. In 2011, Genzyme Corporation was acquired for around $20.1 billion. This biotechnology company...

regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee...

Disease, when it was bought by Genzyme. The patent portfolio was cited in the press releases announcing the deal. Genzyme claims that Dr. Robert Stonehill's...

leukemia in 2001. It is marketed by Genzyme, which acquired the worldwide rights from Bayer AG in 2009. Genzyme was bought by Sanofi in 2011. In August/September...

acetate Teva Pharmaceuticals Subcutaneous 30% 0.3 Aubagio Teriflunomide Genzyme Oral 30% 0.35 Plegridy Interferon beta-1a Biogen Subcutaneous 30% 0.12...

disease. It was discovered at the University of Michigan, developed by Genzyme Corp, and was approved by the FDA in August 2014. Commonly used as the...